Daiichi Sankyo

Rediff.com » News » Daiichi Sankyo

News for Daiichi Sankyo

Business

Zenotech: SC allows Daiichi Sankyo offer

The Supreme Court on Friday allowed Japanese pharma firm Daiichi Sankyo to go ahead with the public offer for an additional 20 per cent stake in Zenotech Laboratories. A Bench headed by Chief......

Ranbaxy to sell Daiichi Sankyo product in Malaysia

Drug firm Ranbaxy Laboratories and Japan's Daiichi Sankyo said on Wednesday Ranbaxy will market its parent company's products in Malaysia as part of their initiative to harness synergies between......

Daiichi Sankyo to offload stake in Sun Pharma

Japanese drug maker Daiichi Sankyo on Monday said its board has approved selling a part or entire 9 per cent holding worth over Rs 22,000 crore (Rs 220 billion) in Indian drug major Sun......

Ranbaxy, Daiichi Sankyo to leverage synergies

Drug firm Ranbaxy Laboratories and its Japanese parent Daiichi Sankyo will integrate their business operations in Thailand as part of strategy to maximise synergies.Both the companies intend to......

Daiichi Sankyo completes Rbxy deal, holds 63.92%

Daiichi Sankyo on Friday said it had achieved closure of the final transfer of shares from the Ranbaxy promoters, the Singh family, to itself, thereby upping its stake to 63.92 per cent in Ranbaxy......

Daiichi Sankyo

News for Daiichi Sankyo

Zenotech: SC allows Daiichi Sankyo offer

Ranbaxy to sell Daiichi Sankyo product in Malaysia

Daiichi Sankyo to offload stake in Sun Pharma

Ranbaxy, Daiichi Sankyo to leverage synergies

Daiichi Sankyo completes Rbxy deal, holds 63.92%

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS